ADMA Biologics: Grossman lists $1.98M in share sales

The proposed sales include up to 135,000 option shares and up to 54,000 shares from restricted-stock-unit vesting.

Available on EDGAR 11/05/2026 - 09:00 PM EST Accepted by SEC EDGAR 11/05/2026 - 09:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

ADMA Biologics, Inc. director and officer Adam S. Grossman’s notice lists 189,000 common shares to be sold, with an aggregate market value of $1,980,720. It covers sales effected on November 5, 2026, and proposed sales during the subsequent 90-day period of up to 135,000 shares acquired or to be acquired through stock-option exercises and up to 54,000 shares from vesting and settlement of restricted stock units.

Up to 30,000 option shares covered by the notice would be acquired upon exercises connected with proposed future sales; acquisition and payment dates for those shares are the applicable exercise and sale dates.

Key Figures

Common shares to be sold: 189,000 shares Aggregate market value: $1,980,720 Option shares: Up to 135,000 shares +2 more

5 metrics

Common shares to be sold 189,000 shares Securities information

Aggregate market value $1,980,720 Securities information

Option shares Up to 135,000 shares Acquired or to be acquired upon exercise for proposed sales during the subsequent 90-day period

Restricted stock unit shares Up to 54,000 shares From vesting and settlement for proposed sales during the subsequent 90-day period

Option shares acquired for proposed future sales Up to 30,000 shares Acquired upon exercise in connection with proposed future sales

Key Terms

restricted stock units, vesting and settlement, Compensatory payment

3 terms

restricted stock units financial

"Vesting and settlement of restricted stock units granted on March 7, 2022."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting and settlement financial

"Vesting and settlement of restricted stock units granted on March 6, 2023."

Compensatory payment financial

"Compensatory payment Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ADMA shares does Adam S. Grossman’s notice cover?

The notice lists 189,000 common shares to be sold, with an aggregate market value of $1,980,720. It covers sales effected November 5, 2026, and proposed sales during the subsequent 90-day period.

How many ADMA option shares are tied to future sales in Adam S. Grossman’s notice?

Up to 30,000 option shares would be acquired upon exercise in connection with proposed future sales. Their acquisition and payment dates are the applicable exercise and sale dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001542517
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ADMA BIOLOGICS, INC.
SEC File Number	001-36728
Address of Issuer	465 STATE ROUTE 17 RAMSEY NEW JERSEY 07446
Phone	(201) 478-5552
Name of Person for Whose Account the Securities are To Be Sold	Grossman Adam S.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Brokerage Services, LLC Attention: 10b5-1 Group 2 Contra Way T2L Merrimack NH 03054	189000	1980720	221854389	11/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/07/2025	Vesting and settlement of restricted stock units granted on March 7, 2022.	Issuer			1014	03/07/2025	Compensatory payment
Common Stock	03/06/2025	Vesting and settlement of restricted stock units granted on March 6, 2023.	Issuer			38986	03/06/2025	Compensatory payment
Common Stock	02/19/2026	Vesting and settlement of restricted stock units granted on February 19, 2025.	Issuer			14000	02/19/2026	Compensatory payment
Common Stock	11/05/2026	Exercise of stock options granted on February 26, 2024.	Issuer			135000	11/05/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This notice covers sales effected on November 5, 2026 and proposed sales during the subsequent 90-day period of up to 135,000 shares acquired or to be acquired upon the exercise of stock options and up to 54,000 shares acquired upon the vesting and settlement of restricted stock units. Up to 30,000 of the option shares covered by this notice will be acquired upon the exercise of options in connection with proposed future sales. The dates of acquisition and payment for those shares will be the applicable dates of exercise and sale.
Date of Notice	11/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam S. Grossman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)